Drug Shortages, Newly Developed Therapies, and Access

ASH provides the following resources to keep physicians informed of newly approved therapies, safety and prescription matters, and shortages of critical hematologic drugs.

Hematologic Risk Evaluation and Mitigation Strategies
Information about hematologic risk evaluation and mitigation strategies(REMs)
High-Cost Hematologic Drug Access
Resources to help clinicians and patients access high-cost hematologic drugs
Hematologic Drug Shortage Information
Information and resources regarding shortages of drugs used to treat patients with hematologic diseases
FDA Alerts
Information about newly approved therapies and other important actions (e.g., updated safety information, new prescribing information) for patients provided in collaboration with the Food and Drug Administration (FDA)